![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 30, 21114-21120, July 23, 1999
From the Albert Einstein College of Medicine, Department of Biochemistry, Bronx, New York 10461
| |
ABSTRACT |
|---|
|
|
|---|
Protozoan parasites lack the pathway of the
de novo synthesis of purines and depend on host-derived
nucleosides and nucleotides to salvage purines for DNA and RNA
synthesis. Nucleoside hydrolase is a central enzyme in the purine
salvage pathway and represents a prime target for the development of
anti-parasitic drugs. The full-length cDNA for nucleoside hydrolase
from Leishmania major was cloned and sequence analysis
revealed that the L. major nucleoside hydrolase shares 78%
sequence identity with the nonspecific nucleoside hydrolase from
Crithidia fasciculata. The L. major enzyme was overexpressed in Escherichia coli and purified to over 95%
homogeneity. The L. major nucleoside hydrolase was
identified as a nonspecific nucleoside hydrolase since it demonstrates
the characteristics: 1) efficient utilization of
p-nitrophenyl Leishmania species are protozoan parasites transmitted
by blood-sucking female phlebotomine sandflies. They infect humans primarily in the Middle East, central Asia, and Africa, but are found
on all continents except Australia (1). Current chemotherapeuric treatments are also toxic to the host. Most of the protozoan parasites lack the pathway for de novo purine synthesis and depend on
purine salvage from the host for DNA and RNA synthesis (2). Several enzymes have been implicated in the purine salvage pathway, including a
cell-surface associated enzyme, 3'-nucleotidase/nuclease, that is
proposed to generate nucleosides. The nucleosides are further metabolized by nucleoside hydrolases, a family of enzymes which hydrolyze the N-glycosidic bond of purine and pyrimidine
ribosides to yield ribose and the bases (3, 4). Phosphoribosyl
transferases are proposed to form the respective nucleotides by
reaction of the bases with 5-phosphoribosyl-1-pyrophosphate (5).
Nucleoside hydrolases and phosphoribosyl transferases have been
characterized from several sources, and the identification of
inhibitors for these enzymes might be of use in parasite infections
(6-10). Structures for the nucleoside hydrolase from Crithidia
fasciculata were reported recently, however, there is no
structural information on nonspecific nucleoside hydrolases from
protozoan parasites with human hosts. The purpose of this study was to
evaluate the properties of nucleoside hydrolase from
Leishmania relative to those from Crithidia and Trypanosoma (11, 13).
Cell-free extracts from a variety of protozoan parasites indicate the
existence of several nucleoside hydrolase isozymes with differing
substrate specificities. The most abundant nucleoside hydrolase in
C. fasciculata is
IU1-nucleoside hydrolase, a
nonspecific enzyme that catalyzes efficient hydrolysis of both purine
and pyrimidine nucleosides (11). A second nucleoside hydrolase from
C. fasciculata, GI-nucleoside hydrolase, prefers purine
nucleosides as substrates (12). In addition to the two nucleoside
hydrolases from C. fasciculata, a purine-preferring
nucleoside hydrolase from the bloodstream form of Trypanosoma
brucei brucei has been characterized and named IAG-nucleoside
hydrolase since the enzyme prefers inosine, adenosine, and guanosine as
substrates (13).
The IU-nucleoside hydrolase from C. fasciculata is the most
extensively studied enzyme in protozoan purine salvage pathways. It has
been cloned and expressed in Escherichia coli and
mutagenesis studies have identified His-241 as a catalytic site residue
that acts as a general acid for leaving-group activation (14). The transition state structure of IU-nucleoside hydrolase, determined by
kinetic isotope effect measurements, has been shown to have characteristics of an oxocarbenium ion (15). The three-dimensional structures of unliganded IU-nucleoside hydrolase and the enzyme complexed with p-aminophenyl-(1S)-iminoribitol, a
transition state inhibitor, have been solved by x-ray crystallography
to 2.5- and 2.3-Å resolution, respectively (7, 16-18).
The sequence alignment search using the amino acid sequence of the
IU-nucleoside hydrolase from C. fasciculata found an
est-cDNA clone of unknown function from Leishmania
major. High sequence identity was established in the N-terminal 48 residues of deduced amino acid sequence (14). We report here the
cloning of the full-length nucleoside hydrolase from L. major, determination of its primary amino acid sequence, its
expression in E. coli, a purification scheme, analysis of
substrate specificity, several nanomolar transition state inhibitors,
and the 2.5-Å x-ray structure of the enzyme.
Cloning and Sequencing--
cDNA clone LM247 phage stock was
generously provided by Dr. J. W. Ajioka from the Laboratory for
Parasite Genome Analysis at Cambridge University. Lambda phage lysates
were prepared from LB plates with dense plaques using bacterial host
strain XL1-blue (Novagen Inc.). Phage DNA was isolated using a phage
purification kit (Novagen Inc.) and was used as a template for PCR
reactions. A 5'-oligonucleotide primer 5'-GCATTTGCGAGCCATGCCG-3' was
designed based on the partial sequence on the 5'-end of the LM247 clone that shows significant sequence identity to the gene sequence of
IU-nucleoside hydrolase from C. fasciculata (14). The 5' primer was used with a 3'-oligonucleotide primer
5'-TAATACGACTCACTATAGCG-3' corresponding to the T7 promoter, which is
located on the vector Expression--
Primers 5'-CATATGCCGCGCAAGATTATTCTC-3' and
5'-GGATCCTCACTGAGGATCGCCGAT-3' were based on the nucleotide sequence of
the 5'- and 3'-regions of the sequenced PCR product and were designed to include restriction sites NdeI and BamHI,
respectively. A stop codon, TGA, was also incorporated into the
3'-primer. These were used to amplify the full-length gene by PCR using
LM247 Lambda phage DNA as template. The PCR product was purified from a
1% agarose gel using the Qiaquick gel extraction kit (QIAGEN Inc.). The cDNA was ligated into the expression vector PMW172 and the construct was transformed into E. coli strain BL21(DE3) for
protein expression. Analysis by SDS-polyacrylamide gel electrophoresis indicated overexpression of a protein with molecular mass of
approximately 34,000 daltons without
isopropyl-1-thio- Enzyme Purification--
The 0.95-kilobase open reading frame
for nucleoside hydrolase in the PMW172 expression vector was expressed
in BL21(DE3) E. coli cells (Novagen Inc.). Cells were grown
in LB medium containing 50 µg/ml ampicillin. Cell cultures were grown
continuously in shaken flasks for 7 h at 37 °C and harvested by
centrifugation. The cells were washed with and resuspended in an equal
volume 20 mM Tris-HCl, pH 7.4, 1 mM
dithiothreitol, 1 mM EDTA, 15 µM phenylmethylsulfonyl fluoride, and 50 mM NaCl. The cells
were frozen and stored at
Frozen cells were thawed in warm water and disrupted with 4 cycles of
French press treatment. The cell lysate was centrifuged at 15,000 rpm
for 80 min. Neomycin sulfate (10% w/v in H2O) was added
slowly with vigorous stirring to a final concentration of 1% (w/v).
After centrifugation, solid ammonium sulfate was added to the
supernatant to a final concentration of 40%. The pellet was collected
by centrifugation, resuspended in a minimum volume of 20 mM
triethanolamine, pH 7.8, containing 15 µM
phenylmethylsulfonyl fluoride (buffer A), and dialyzed overnight at
4 °C against the same buffer. The dialysate was applied to a FastQ
anion exchange chromatography column equilibrated with buffer A. The
column was washed with 1.5 column volumes of buffer A and eluted with 4 column volumes of buffered 0-0.3 M NaCl in a linear
gradient. The nucleoside hydrolase was eluted between 2.5 and 3.0 column volumes. The fractions containing the nucleoside hydrolase were
pooled, concentrated, and loaded on a Superdex 200 chromatography
column equilibrated with 10 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 1 mM EDTA and eluted with the same
buffer. The fractions containing nucleoside hydrolase activity were
pooled, dialyzed against 20 mM triethanolamine, pH 7.3, and
concentrated by ultrafiltration. The protein was rapidly frozen and
stored at Crystallization--
Recombinant nucleoside hydrolase from
L. major was crystallized using hanging-drop vapor diffusion
at 18 °C. The protein was crystallized in the presence of
hypoxanthine, which is a product of the enzyme and also inhibits the
enzyme at high concentration. Saturated hypoxanthine (6 µl) was air
dried on a glass coverslip. On top of the dried hypoxanthine, 3 µl of
13-15 mg/ml protein was mixed with an equal volume of mother liquid
containing 100 mM MES, pH 6.5, and 16% polyethylene glycol
4000, and was equilibrated against 1.0 ml of the mother liquid in the
well. Crystals appeared in 3-5 days in the presence of some amorphous
precipitate. Crystals grew in clusters, but single crystals could be
separated from the clusters. Diffraction from these crystals is
consistent with the monoclinic space group P21 with
a = 81.8 Å, b = 79.2 Å,
c = 109.8 Å, and Data collection and Processing--
X-ray diffraction data were
collected at room temperature from a single crystal of nucleoside
hydrolase using a Siemens X-1000 area detector coupled to a Rigaku
rotating anode x-ray generator operating at 50 KV and 80 mA. Radiation
from the copper anode was focused through Cross-coupled Gobel mirrors
(Bruker AXS) and a 0.3-mm collimator. Indexing and integration of the
data frames were carried out using program XDS (19) and the data was
scaled using SCALEPACK from the DENZO package (20). The data set used for the molecular replacement and structural refinement had an overall
completeness of 84% to 2.5-Å resolution with an
Rsym of 7.2%. Data collection statistics are
shown in Table I.
Molecular Replacement and Structural Refinement--
The
structure of nucleoside hydrolase from L. major was solved
by molecular replacement using the AmoRe software package implemented in CCP4 (21). Coordinates of the IU-nucleoside hydrolase dimer from
C. fasciculata were used as the search model with all side chains that are different from L. major nucleoside hydrolase
trimmed to alanine (7). Temperature factors of all atoms were reset to
20.0 Å2. Two solutions, corresponding to the orientations
and locations of the two homodimers in the asymmetric unit, were
generated using 8.0-4.0 Å data.
The tetrameric structure generated by molecular replacement was
subjected to rigid-body refinement using XPLOR (22). The Rcryst dropped from 41.7 to 32.6% and
Rfree was also reduced from 39.5% to 31.5 after
40 steps of rigid-body refinement using 8.0-4.0 Å data. Program O
(23) was used to view the structure and build the missing side chains
into the electron densities in the 2 Fo Substrate Activity Assay--
Nucleoside hydrolase was assayed
at room temperature or at 30 °C in 50 mM Hepes, pH 8.0. Hydrolysis of inosine to hypoxanthine and ribose was followed by
continuous reading of optical absorbance at 280 nm (11). Hydrolysis of
p-nitrophenyl Sequence Comparison--
The amino acid sequence of the nucleoside
hydrolase from L. major contains a total of 315 residues
including the N-terminal Met (Table II).
Sequence alignment was performed with the IU-nucleoside hydrolase from
C. fasciculata and the IAG-nucleoside hydrolase from
T. brucei brucei (14, 25). The L. major
nucleoside hydrolase shares 78% sequence identity with the
IU-nucleoside hydrolase but only 20% sequence identity with the
IAG-nucleoside hydrolase. The IU-nucleoside hydrolase from C. fasciculata requires the presence of all three hydroxyl groups,
(2'-, 3'-, and 5'-hydroxyls), in the nucleosides to ensure efficient
substrate binding and catalysis (11). Residues involved in hydrogen
bonding of the three hydroxyls in the C. fasciculata enzyme
include Asp-10, Asp-14, Asp-15, Asn-39, and Asp-242 (Asp-241 in
L. major because of one deletion in the amino acid sequence)
for the 2'- and 3'-hydroxyls and Asn-160, Glu-166, and Asn-168 for the
5'-hydroxyl (7). All these residues involved in substrate recognition
are conserved in the L. major nucleoside hydrolase (Table
II). In the IAG-nucleoside hydrolase, the only residues in contact with
ribosyl hydroxyls that are not conserved are Asn-39 and Asn-160. In
IAG-NH, Asn-39 is replaced by an aspartate which has a similar hydrogen
bonding ability, and Asn-160 is replaced by Thr near a 6-amino acid
insertion (Table II). The insertion of amino acids GNVFLP in IAG-NH
prior to the position corresponding to Asn-160 in the L. major enzyme is likely to be involved in the ability of the IAG-NH
to hydrolyze deoxynucleosides more efficiently than the nonspecific
nucleoside hydrolases (11, 13).
His-241 in the IU-NH from C. fasciculata has been proposed
to be involved in leaving group activation. Mutation of H241A in the
IU-NH resulted in over 2000-fold loss of activity in inosine hydrolysis
with no loss in the rate of hydrolysis of p-nitrophenyl Substrate Specificity--
The extensive amino acid sequence
similarity between nucleoside hydrolases from C. fasciculata
and L. major suggested closely related catalytic properties.
The p-nitrophenyl Transition-state Inhibitors for L. major Nucleoside
Hydrolase--
Iminoribitols with 1-S substitutions are
transition state inhibitors for the IU-NH from C. fasciculata (6). Inhibitors containing 9-deazadenosine (immucillin
A) or 4-amino-5-carbonylamino-3-pyrrolyl (immucillin ACAP) substituents
of iminoribitol have been shown to inhibit both C. fasciculata and T. brucei brucei nucleoside hydrolases
with nanomolar inhibition
constants.2 These analogues
of the nucleoside hydrolase transition state gave inhibition constants
of 6.5 and 15 nM for the nucleoside hydrolase from L. major (Table V). These dissociation
constants vary less than 2-fold from those of C. fasciculata
nucleoside hydrolase but differ more from the Ki
values obtained with the enzyme from T. brucei brucei.
Inosine is the best substrate for nucleoside hydrolase from L. major with a Km of 445 µM. The
inhibitors of Table V are powerful inhibitors for this enzyme with
immucillin A binding 29,700 times more tightly than the
Km for inosine, while immucillin ACAP gives a
Km/Ki ratio of 68,460. These
inhibitors would compete very favorably for the catalytic site of
nucleoside hydrolase, even in the presence of nanomolar inhibitor and
micromolar substrate.
Overall Fold of the L. major Nucleoside Hydrolase--
Nucleoside
hydrolase from L. major is folded into a single domain
structure containing 12 Quaternary Structure--
L. major nucleoside hydrolase
forms a homotetramer that is related by a 222 point symmetry in the
asymmetric unit. The four molecules are nearly identical because of the
noncrystallographic symmetry restraints applied in the refinement. The
packing of the tetrameric structure is rather loose. The tightest
interface (A/B or C/D) in the tetramer buries a total of 1957 Å2 surface area, which represents 7.3% of the total
solvent accessible surface area for each molecule. The A/B interface
includes the Ca2+-binding Site--
The crystal structures of apo
and complexed IU-nucleoside hydrolase from C. fasciculata
have revealed a Ca2+ ion bound at the active site (7, 18).
Elemental analysis confirmed that the Ca2+ binds to the
IU-nucleoside hydrolase with 1:1 molar ratio (7). In the L. major nucleoside hydrolase crystal structure, a single Ca2+ ion is located in each of the molecules in the
tetramer and the electron density in the 2 Fo Structural Comparison of Nucleoside Hydrolases--
The L. major nucleoside hydrolase is structurally similar to the C. fasciculata IU-nucleoside hydrolase (Fig.
3). This is expected from the 78% amino
acid sequence identity and conservation of sequences in the catalytic
site. The overlap of C Conclusions--
L. major is the causative parasite for
one of the significant world health infectious diseases. This report is
the first structural description of a nucleoside hydrolase from the
organism. Although the enzyme is established as a member of the
nonspecific nucleoside hydrolases, it has a unique substrate
specificity with strong preference for inosine. Its mechanism includes
a tightly bound catalytic site Ca2+. Two inhibitors are
described that bind >105-fold tighter than the
Km for substrate. This information may be useful in
the design of anti-Leishmania agents.
-D-ribofuranoside as a
substrate; 2) recognition of both inosine and uridine nucleosides as
favored substrates; and 3) significant activity with all of the
naturally occurring purine and pyrimidine nucleosides. The crystal
structure of the L. major nucleoside hydrolase revealed a
bound Ca2+ ion in the active site with five oxygen ligands
from Asp-10, Asp-15 (bidentate), Thr-126 (carbonyl), and Asp-241. The
structure is similar to the C. fasciculata IU-nucleoside
hydrolase apoenzyme. Despite the similarities, the catalytic
specificities differ substantially. Relative values of
kcat for the L. major enzyme with
inosine, adenosine, guanosine, uridine, and cytidine as substrates are 100, 0.5, 0.5, 27 and 0.3; while those for the enzyme from C. fasciculata are 100, 15, 14, 510, and 36 for the same substrates. Iminoribitol analogues of the transition state are nanomolar
inhibitors. The results provide new information for purine and
pyrimidine salvage pathways in Leishmania.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
ZAPII of the LM247 clone. A PCR product of
approximately 1.0 kilobases was ligated into the TA cloning vector
(Invitrogen Inc.). The full sequence of the PCR product showed an 78%
amino acid sequence identity to the protein sequence of the
IU-nucleoside hydrolase from C. fasciculata.
-D-galactopyranoside induction. The
crude cell extracts gave nucleoside hydrolase activity with both
inosine and p-nitrophenyl
-D-ribofuranoside
as substrates.
70 °C.
70 °C.
= 91.6o.
The crystals contain a tetramer in the asymmetric unit with a
Vm = 2.54 Å3/Da and a calculated
solvent content of 56%.
Fc map. Strict noncrystallographic symmetry
constraints were applied in the initial cycle of refinement and relaxed
in the subsequent cycles. The final structure contains residues 2-313 in all four subunits, one Ca2+ for each subunit and a total
of 100 water molecules in the tetramer with
Rcryst of 20.3% and
Rfree of 25.5%. The model shows good geometry
with 85.3% of the residues in the most favored region, 13.6% in the
additionally allowed region, and 1.1% in the generously allowed region
by PROCHECK (24). Statistics for the refinement are summarized in Table
I.
Summary of crystal structure determination
-D-ribofuranoside was followed
by release of the p-nitrophenylate anion which has strong
absorbance at 400 nm with extinction coefficient of 14,600 M
1 cm
1 under the assay
condition (25). The hydrolysis of guanosine, adenosine, cytidine, and
uridine was monitored by release of reducing sugar at room temperature
(11). The inhibition constants for inhibitors were measured at a fixed
concentration of p-nitrophenyl
-D-ribofuranoside and variable concentrations of
inhibitor. The results were fit to the equation: v = VmA/[Km(1 + I/Ki) + A], where
v = the initial rate of product formation,
Vm = maximum catalytic rate, A = substrate concentration, Km = Michaelis constant,
and Ki = the dissociation constant for the
enzyme-inhibitor complex. This analysis makes the assumption that
A and I (the inhibitor) compete for the catalytic site.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
Primary sequence comparison of nucleoside hydrolases
-D-ribofuranoside, a substrate that is not activated by
leaving group protonation (14, 26). This His residue (242) is conserved in the L. major nucleoside hydrolase. The IAG-nucleoside
hydrolase from T. brucei brucei has a Trp in this position
which is likely to be involved in its leaving group specificity for
purines, possibly as a result of base stacking with Trp. At present
there is no structural information for the IAG-nucleoside hydrolase.
-D-ribofuranoside has been
shown to be a good substrate for the nonspecific nucleoside hydrolase
but a poor one for purine-specific nucleoside hydrolases including the
IAG-NH from T. brucei brucei (13). This discrimination arises from differences in the catalytic mechanism for transition state
formation. Purine-specific nucleoside hydrolases lower the energy of
activation to achieve the transition state by applying similar energies
to both leaving group activation (protonation or hydrogen bonding) and
ribosyl activation (forming a ribooxocarbenium ion). Nonspecific
nucleoside hydrolases typified by the IU-NH from C. fasciculata invest most of their catalytic energy into ribooxocarbenium formation. The substrate p-nitrophenyl
-D-ribofuranoside cannot be protonated on the leaving
group, but is susceptible to fascile decomposition when the ribosyl
group is converted to the oxocarbenium ion. The nucleoside hydrolase
from L. major demonstrates the characteristics expected for
nonspecific nucleoside hydrolases, including, 1) efficient utilization
of p-nitrophenyl
-D-ribofuranoside as a
substrate; 2) recognition of both inosine and uridine nucleosides as
favored substrates; and 3) some catalytic activity with all of the
naturally occurring purine and pyrimidine nucleosides (Table III). Despite these similarities between
the C. fasciculata and L. major enzymes,
differences exist in catalytic specificity and efficiency. The
kcat values for inosine of 28 s
1
for the C. fasciculata and 119 s
1 for the
L. major establish a 4.25-fold increased catalytic turnover for the best purine substrate. The specificity for purines and pyrimidines also differs significantly. Catalytic turnover ratios for
uridine/inosine are 5.1 for the C. fasciculata enzyme but only 0.27 for that from L. major. Both the
kcat and relative rates of hydrolysis of
adenosine and guanosine are slower for the L. major enzyme
(Table IV). These properties indicate
that the L. major enzyme has evolved to catalyze an
increased turnover of inosine, with a loss of catalytic efficiency for
other nucleosides. Hypoxanthine is thought to be the major precursor
for purine salvage in L. major, and the substrate
specificity of this enzyme is well suited to the role (1, 2). Metabolic
efficiency in a salvage pathway benefits from enzymes with
kcat/Km values near diffusion
control, approximately 108 M
1
s
1 for the nucleoside hydrolases. The nonspecific
nucleoside hydrolase described here is approximately 2 orders of
magnitude from catalytic perfection because of a high
Km value. It is possible that inosine transport by
the protozoa provides intracellular concentrations above the low
micromolar levels found in blood.
Kinetic parameters for nucleoside hydrolase from L. major
Comparison of catalytic properties for nucleoside hydrolases
Transition state inhibitors for nucleoside hydrolases
-helices and 10
-strands (Fig. 1). The core of the structure consists of
a 7-stranded parallel
-sheet (
3, 63-65;
2, 28-35;
1,
3-9;
4, 121-125;
5, 148-152;
6, 186-189; and
10,
288-290) and two
-helices (
1, 13-24 and
11, 242-249). Five
-helices (
3, 105-115;
4, 130-138;
5, 141-145;
7,
173-180; and
6, 167-170) stack above the central
-sheet and
three
-helices (
10, 213-228;
12, 296-310; and
9,
201-210) sit beneath the two helices (
1,
11) in the core. Two
-helices (
2, 42-55 and
8, 191-194) are located at the either
side of the core. Two 2-stranded antiparallel
-sheets (
7,
254-257 and
10, 291-294;
8, 261-263 and
9, 274-276) are
oriented perpendicular to each other and protecting the core structure
from the right side. A bound Ca2+ ion is located in the
active site cleft formed by
2,
1,
4,
5,
1, and
11 in
the core. The enzyme was co-crystallized with saturating hypoxanthine.
Although the addition of hypoxanthine improved the crystal morphology,
no hypoxanthine molecules were found either in the active site or other
part of the protein structure. The long loop connecting
3 and
3
is projecting outwards and is very flexible. Part of this loop
(residues 76-83) was modeled as polyalanine because of the poor side
chain densities in the electron density maps.

View larger version (55K):
[in a new window]
Fig. 1.
Stereoview of the monomer of L. major nucleoside hydrolase (a) with a view
of the bound Ca2+ (green). The
subunit packing (b) demonstrates the novel interfaces of the
tetramer with the locations of the catalytic sites indicated with
Ca2+. Figs. 1-3 were generated using SETOR (27).
8/
9 (263-282) region and the connection between
5 and
6 (155-165). The interactions are mostly hydrophobic van
der Waals contributed by Leu-269, Val-275 from both subunits and two
hydrogen bond pairs between side chain of Glu-264 and backbone N of
Leu-269, and between side chains of His-157. The other two interfaces
(A/D or B/C, A/C or B/D) bury a total of 1685 and 82 Å2
surface area, respectively.
Fc maps indicates that the Ca2+ ion is
fully occupied in the active site. Crystal structures of
Ca2+ complexes indicate that Ca2+ usually binds
to oxygen atoms in chelating complexes and the preferred coordination
numbers range from 6 to 8 (28). In the L. major nucleoside
hydrolase, however, only five oxygen ligands are found chelating the
Ca2+. The remaining chelation sites are open to solvent
contact and it is likely that one or more of these additional sites are
in exchange with water. In the structure of IU-NH from C. fasciculata, the sixth chelate position was occupied by an ordered
water, but no ordered water is seen here. The distances for the
coordination are 2.6 Å to the OD1 of Asp-10, 2.8 and 2.9 Å,
respectively, to the OD2 and OD1 of Asp-15, 2.7 Å to the OD2 of
Asp-241, and 2.5 Å to the carbonyl O of Thr-126 (Fig.
2). The Ca2+ is located near
the bottom of the active site cleft and the side chains of these
residues point up to chelate the Ca2+. In the C. fasciculata IU-nucleoside hydrolase apoenzyme structure, the
coordination to Ca2+ from protein atoms is very similar,
but a water molecule is located above the Ca2+ to provide
the sixth ligand. In the C. fasciculata structure with bound
inhibitor, the 2'- and 3'-hydroxyls from the bound transition state
inhibitor provide two more ligands to the Ca2+. The
mechanistic role of the Ca2+ is to orient substrate in the
active site and to position the water molecule for attack at the
C1'-anomeric carbon following the formation of the ribooxocarbenium ion
(7). The amino acid residues that make contact to the Ca2+
are completely conserved in all three of the well characterized nucleoside hydrolases (Table II).

View larger version (20K):
[in a new window]
Fig. 2.
Stereoview of the contacts between L. major nucleoside hydrolase with the Ca2+
(blue). The distances are in angstroms.
traces of the two structures reveals
differences in the two flexible loop regions. These are the long loop
connecting
3 and
3 (76-83), and the loop immediately after
10
(230-235). The root mean square deviation between all C
atoms
excluding the two flexible loop regions is 0.4 Å between the L. major enzyme and the C. fasciculata apoenzyme, and 0.8 Å between the L. major enzyme and the C. fasciculata complex structure. In the C. fasciculata
complex structure, the two flexible loops moved closer to the active
site of the enzyme upon binding of a transition state inhibitor
(7).

View larger version (62K):
[in a new window]
Fig. 3.
Stereoview comparison of the L. major nucleoside hydrolase with the C. fasciculata nucleoside hydrolase apoenzyme
(a) and the enzyme complexed with
p-aminophenyl-(1S)-iminoribitol, a
transition state inhibitor (b). Most of the
differences occur in the long loop connecting
3 and
3 (Loop I)
and the loop immediately after
10 (Loop II).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Peter Tyler and Richard Furneaux of the Carbohydrate Chemistry Team, Industrial Research Ltd., for supplying the iminoribitol inhibitors of Table V. We thank Dr. Robert Miles for determination of Ki values for the L. major nucleoside hydrolase.
| |
FOOTNOTES |
|---|
* This work was supported by Research Grant GM41916 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. E-mail: almo@
aecom.yu.edu.
2 R. W. Miles, P. C. Tyler, G. B. Evans, R. H. Furneaux, D. W. Parkin, and V. L. Schramm, submitted for publication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: IU, inosine-uridine; GI, guanosine-inosine; IAG, inosine, adenosine, guanosine; PCR, polymerase chain reaction; MES, 4-morpholineethanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | David, J. R. (1984) in Tropical and Geographical Medicine (Warren, K. S. , and Mahmoud, A. A. F., eds) , pp. 125-137, McGraw-Hill Book Co., New York |
| 2. | Hammond, D. J., and Gutteridge, W. E. (1984) Mol. Biochem. Parasitol. 13, 243-261[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Neubert, T. A.,
and Gottlieb, M.
(1990)
J. Biol. Chem.
265,
7236-7242 |
| 4. |
Miller, R. L.,
Sabourin, C. L. K.,
Krenitsky, T. A.,
Berens, R. L.,
and Marr, J. J.
(1984)
J. Biol. Chem.
259,
5073-5077 |
| 5. |
Tuttle, J. V.,
and Krenitsky, T. A.
(1980)
J. Biol. Chem.
255,
909-916 |
| 6. | Parkin, D. W., Limberg, G., Tyler, P. C., Furneaux, R. H., Chen, X. Y., and Schramm, V. L. (1997) Biochemistry 36, 3528-3534[Medline] [Order article via Infotrieve] |
| 7. | Degano, M., Almo, S. C., Sacchettini, J. C., and Schramm, V. L. (1998) Biochemistry 37, 6277-6285[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Li, C. M., Tyler, P. C., Furneaux, R. H., Kicska, G., Xu, Y., Grubmeyer, C., Girvin, M. E., and Schramm, V. L. (1999) Nat. Struct. Biol. 6, 582-587[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Shi, W., Li, C. M., Tyler, P. C., Furneaux, R. H., Grubmeyer, C., Schramm, V. L., and Almo, S. C. (1999) Nat. Struct. Biol. 6, 588-593[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Shi, W., Li, C. M., Tyler, P. C., Furneaux, R. H., Cahill, S. M., Girvin, M. E., Grubmeyer, C., Schramm, V. L., and Almo, S. C. (1999) Biochemistry, in press |
| 11. |
Parkin, D. W.,
Horenstein, B. A.,
Abdulah, D. R.,
Estupinan, B.,
and Schramm, V. L.
(1991)
J. Biol. Chem.
266,
20658-20665 |
| 12. |
Estupinan, B.,
and Schramm, V. L.
(1994)
J. Biol. Chem.
269,
23068-23073 |
| 13. |
Parkin, D. W.
(1996)
J. Biol. Chem.
271,
21713-21719 |
| 14. | Gopaul, D. N., Meyer, S. L., Degano, M., Sacchettini, J. C., and Schramm, V. L. (1996) Biochemistry 35, 5963-5970[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Horenstein, B. A., Parkin, D. W., Estupinan, B., and Schramm, V. L. (1991) Biochemistry 30, 10788-10795[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Horenstein, B. A., and Schramm, V. L. (1993) Biochemistry 32, 9917-9925[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Horenstein, B. A., and Schramm, V. L. (1993) Biochemistry 32, 7089-7097[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Degano, M., Gopaul, D. N., Scapin, G., Schramm, V. L., and Sacchettini, J. C. (1996) Biochemistry 35, 5971-5981[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Kabsch, W. (1988) J. Appl. Cryst. 21, 67-71 |
| 20. | Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326 |
| 21. | Navaza, J. (1994) Acta Cryst. Sect. A 50, 157-163[CrossRef] |
| 22. | Brunger, A. T. (1992) X-PLOR version 3.1 , Yale University Press, New Haven, CT |
| 23. | Jones, T. A. (1985) Methods Enzymol. B115, 157-171[Medline] [Order article via Infotrieve] |
| 24. | Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283-291 [CrossRef] |
| 25. |
Pelle, R.,
Schramm, V. L.,
and Parkin, D. W.
(1998)
J. Biol. Chem.
273,
2118-2126 |
| 26. | Mazzella, L. J., Parkin, D. W., Tyler, P. C., Furneaux, R. H., and Schramm, V. L. (1996) J. Am. Chem. Soc. 118, 2111-2112[CrossRef] |
| 27. | Evan, S. V. (1998) J. Mol. Graphics 11, 134-138[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Katz, A. K., Glusker, J. P., Beebe, S. A., and Bock, C. W. (1996) J. Am. Chem. Soc. 118, 5752-5763[CrossRef] |
This article has been cited by other articles:
![]() |
M. Sterk, J. Muller, A. Hemphill, and N. Muller Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin Microbiology, December 1, 2007; 153(12): 4150 - 4158. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Al-Wabel, W. K. Tonui, L. Cui, S. K. Martin, and R. G. Titus Protection of Susceptible BALB/c Mice from Challenge with Leishmania major by Nucleoside Hydrolase, a Soluble Exo-antigen of Leishmania Am J Trop Med Hyg, December 1, 2007; 77(6): 1060 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Boitz and B. Ullman A Conditional Mutant Deficient in Hypoxanthine-guanine Phosphoribosyltransferase and Xanthine Phosphoribosyltransferase Validates the Purine Salvage Pathway of Leishmania donovani J. Biol. Chem., June 9, 2006; 281(23): 16084 - 16089. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Kim, J.-H. Lee, W.-S. Lee, and W.-G. Bang Genes encoding ribonucleoside hydrolase 1 and 2 from Corynebacterium ammoniagenes. Microbiology, April 1, 2006; 152(Pt 4): 1169 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Al-Salabi, L. J. M. Wallace, and H. P. de Koning A Leishmania major Nucleobase Transporter Responsible for Allopurinol Uptake Is a Functional Homolog of the Trypanosoma brucei H2 Transporter. Mol. Pharmacol., April 1, 2003; 63(4): 814 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Versees, K. Decanniere, E. Van Holsbeke, N. Devroede, and J. Steyaert Enzyme-Substrate Interactions in the Purine-specific Nucleoside Hydrolase from Trypanosoma vivax J. Biol. Chem., May 3, 2002; 277(18): 15938 - 15946. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mitterbauer, T. Karl, and G. Adam Saccharomyces cerevisiae URH1 (Encoding Uridine-Cytidine N-Ribohydrolase): Functional Complementation by a Nucleoside Hydrolase from a Protozoan Parasite and by a Mammalian Uridine Phosphorylase Appl. Envir. Microbiol., March 1, 2002; 68(3): 1336 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ogawa, S. Takeda, S.-X. Xie, H. Hatanaka, T. Ashikari, T. Amachi, and S. Shimizu Purification, Characterization, and Gene Cloning of Purine Nucleosidase from Ochrobactrum anthropi Appl. Envir. Microbiol., April 1, 2001; 67(4): 1783 - 1787. [Abstract] [Full Text] |
||||
![]() |
C. Petersen and L. B. Moller The RihA, RihB, and RihC Ribonucleoside Hydrolases of Escherichia coli. SUBSTRATE SPECIFICITY, GENE EXPRESSION, AND REGULATION J. Biol. Chem., January 5, 2001; 276(2): 884 - 894. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||